FDA increases control over laboratory-developed tests after COVID-19 fiasco

The FDA is now classifying LDTs as medical devices. This follows criticism following the FDA not approving COVID-19 rapid tests more quickly in 2020.

Related Keywords

United States ,Americans ,Jeff Shuren ,Elizabeth Holmes ,Robert Califf ,Senate Health ,Pensions Committee ,Drug Administration ,Bill Cassidy ,